Risultati di ricerca
16 ore fa · In terms of grant support, as the Duke site PI for the Rare Thrombotic Diseases Clinical Research Network (NIH U54 HL77878; PI Dr T Ortel), patients were enrolled for this prospective, observational cohort study that evaluated the anti-heparin/platelet factor 4 antibodies, that commonly develop after cardiac surgery, as an independent risk factor for early and late thromboembolic complications.
